Evolution and commercialisation of cell and gene therapies Satyen Sanghavi, Founder & CSO, Regrow Biosciences Feb 14, 2025 Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global…
Regrow Biosciences gets US FDA nod for phase-II trials of Ossgrow for Osteonecrosis in US EP News Bureau May 23, 2022 The company moves one-step closer to attain a global market monopoly estimated at $5 billion through this feat
